Form 8-K - Current report:
SEC Accession No. 0001104659-25-018299
Filing Date
2025-02-27
Accepted
2025-02-27 17:00:21
Documents
17
Period of Report
2025-02-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257773d1_8k.htm   iXBRL 8-K 30657
2 EXHIBIT 2.1 tm257773d1_ex2-1.htm EX-2.1 41594
3 EXHIBIT 10.1 tm257773d1_ex10-1.htm EX-10.1 31279
4 EXHIBIT 99.1 tm257773d1_ex99-1.htm EX-99.1 10742
8 GRAPHIC tm257773d1_ex99-1img001.jpg GRAPHIC 5542
  Complete submission text file 0001104659-25-018299.txt   317930

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mbio-20250221.xsd EX-101.SCH 3021
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20250221_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20250221_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT tm257773d1_8k_htm.xml XML 3556
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 25680419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)